Browsing "Hematology-Oncology" by Publication Year :

Jump to a point in the index:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 101 to 120 of 373

Pub YearTitleAJOU Author(s)
2020Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2노진, 박준성, 정성현, 한재호
2020Clinical outcomes of early-progressed follicular lymphoma in Korea: A multicenter, retrospective analysis최윤석
2020Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)강석윤
2020Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931)안미선
2020A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells김철호, 이현우, 정근옥, 함석진
2020DeepBTS: Prediction of recurrence-free survival of non-small cell lung cancer using time-binned deep neural network이현우
2019Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System정성현
2019The comparison of Carfilzomib, and dexamethasone versus pomalidomide-based combination chemotherapy after a 2nd-line therapy in relapsed and refractory multiple myeloma patients박준성
2019Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression강석윤, 김장희, 박태준, 최용원
2019Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death최경숙, 최용원
2019A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer고영화, 안미선, 이수진
2019Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial이현우
2019EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment강석윤
2019Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?강석윤, 안미선, 이현우, 최용원, 최진혁
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤
2019Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial강석윤
2019Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial이현우
2019Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients고영화, 이현우, 정준호, 한재호, 함석진
2019The role of surgical resection before palliative chemotherapy in advanced gastric cancer강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤, 안미선, 이현우
1 2 3 4 5 6 7 8 9 10 11 19

Browse